Latest News Archive
Please select Category, Year, and then Month to display items
23 November 2022
|
Story André Damons
![]()
Prof Motlalepula Matsabisa, Professor and Director of Pharmacology, will play host to the various stakeholders to network and share knowledge on current developments in indigenous knowledge research and product development, biodiversity, innovation, and commercialisation of the IK-based research products. The Indigenous Knowledge System (IKS) for Health unit in the Department of Pharmacology within the UFS Faculty of Health Sciences was last year awarded an annual Technology Innovation Agency Platform (TIA) grant of R17 million for the next five years.
The research and teaching programme in the School of Clinical Medicine has since been rebranded and is now known as the African Medicines Innovation and Technology Development Platform (AMITD), which will strive to respond to community health needs and address industry research needs and challenges.
The indaba will showcase progress made by TIA and other entities in enriching the development and commercialisation of IK-based innovations. It will take place from 24 to 25 November 2022 in the Equitas Senate Hall at the UFS.
Prof Matsabisa is the chairperson of the World Health Organisation’s (WHO) Regional Expert Advisory Committee on Traditional Medicines for COVID-19. He is also a visiting professor at the Beijing University of Chinese Medicine (BUCM) in Beijing, China, and the Deputy President of the South African Society for Basic and Clinical Pharmacology.
Junior researcher makes Kovsies proud
2014-11-11
Herkulaas Combrink received the Junior Researcher Award at the 3rd Annual Health Research Day held on 30 and 31 October 2014. On this day, clinicians and scientists shared information on research that will impact health in the Free State.
Combrink is a student in the Faculty of Health Sciences’ Department of Human Genetics, as well as Medical Science intern with the Health Professions Council of South Africa (HPCSA). His research project: ‘Familial Breast Cancer in BRCA1 and BRCA2 within the Indian population of South Africa’ forms part of an umbrella study which looks at the various populations of South Africa for familial breast cancer mutations within BRCA1 and BRCA2 genes, so that diagnostic panels can be created. This is the first study of its kind to be done on this population group in South Africa.
He says: “I am passionate about my research and the impact of my work. I am hard-working and believe in the value of my contribution to science. My philosophy is that theory must always be put into practice. I apply this philosophy to everything I pursue.”
The research week was held by the School of Medicine in conjunction with the Free State Department of Health.